NEW YORK (GenomeWeb News) – Link Technologies has licensed diagnostic reagent-related technology from the University of Manchester that it intends to market worldwide, the Scottish company said today.

Under the agreement with the University of Manchester Intellectual Property Limited, the firm acquired the rights to make and sell oligonucleotide reagents using the university's exciplex technology. It also will collaborate with the university to further develop the existing technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A company hopes to capture the genetic diversity in India to power tailored therapeutics, BBC News reports.

Researchers tie variants in seven genes to insomnia risk, Live Science reports.

The US Environmental Protection Agency has approved an RNAi-based insecticide, according to the Atlantic.

In PLOS this week: locus near OAS1 linked to Sjogren's syndrome, rotavirus reassortment events uncovered by sequencing, and more.